CIK 0001509261 · Non-accelerated filer<br>Smaller reporting company
Rezolute, Inc.
Sign in to watch- Ticker
- RZLT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- NV
- Entity type
- operating
- EIN
- 273440894
- Phone
- 650-206-4507
- Business address
- 275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY, CA, 94065
- Former names
- AntriaBio, Inc., FITS MY STYLE INC
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Material agreement · Agreement ended · Executive or director change
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- DEF 14A Proxy Proxy Statement
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure
- 4 Grant or award Chief Commercial Officer acquired 25,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 8-K Event Material agreement · Executive or director change · Regulation FD disclosure
- EFFECT Other Notice of Effectiveness
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 8-K Event Regulation FD disclosure
- S-3 Offering Registration Statement
- 4 Open-market buy Chief Medical Officer bought 2,500 shares at $4.38 ($10,939)
Page 4 of 38 · 760 filings